Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results fr... von Krop, Ian E, Dr, Kim, Sung-Bae, Prof, Martin, Antonio Gonzalez, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, MD, Badovinac-Crnjevic, Tanja, MD, Hoersch, Silke, MSc, Smitt, Melanie, MD, Wildiers, Hans, Prof

Volltext

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial von Krop, Ian E, Dr, Kim, Sung-Bae, Prof, González-Martín, Antonio, MD, LoRusso, Patricia M, Prof, Ferrero, Jean-Marc, Prof, Smitt, Melanie, MD, Yu, Ron, PhD, Leung, Abraham C F, MD, Wildiers, Hans, Prof

Volltext

Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T‐DM1) vs. treatment of physician's choice in previously treated HER2‐pos... von Kim, Sung‐Bae, Wildiers, Hans, Krop, Ian E., Smitt, Melanie, Yu, Ron, Lysbet de Haas, Sanne, Gonzalez‐Martin, Antonio

Volltext

Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer von Redondo, Andres, Colombo, Nicoletta, McCormack, Mary, Dreosti, Lydia, Nogueira-Rodrigues, Angelica, Scambia, Giovanni, Lorusso, Domenica, Joly, Florence, Schenker, Michael, Ruff, Paul, Estevez-Diz, Maria, Irahara, Natsumi, Donica, Margarita, Gonzalez-Martín, Antonio

Volltext

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial von Ledermann, Jonathan A, Prof, Embleton, Andrew C, MSc, Raja, Fharat, BMBCh, Perren, Timothy J, Prof, Jayson, Gordon C, Prof, Rustin, Gordon J S, Prof, Kaye, Stan B, Prof, Hirte, Hal, MD, Eisenhauer, Elizabeth, Prof, Vaughan, Michelle, MB, Friedlander, Michael, Prof, González-Martín, Antonio, MD, Stark, Daniel, MD, Clark, Elizabeth, BSc, Farrelly, Laura, MSc, Swart, Ann Marie, Prof, Cook, Adrian, MSc, Kaplan, Richard S, Prof, Parmar, Mahesh K B, Prof

Volltext

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial von Mirza, Mansoor R., González‐Martín, Antonio, Graybill, Whitney S., O’Malley, David M., Gaba, Lydia, Stephanie Yap, Oi Wah, Guerra, Eva M., Rose, Peter G., Baurain, Jean‐François, Ghamande, Sharad A., Denys, Hannelore, Prendergast, Emily, Pisano, Carmela, Follana, Philippe, Baumann, Klaus, Calvert, Paula M., Korach, Jacob, Li, Yong, Malinowska, Izabela A., Gupta, Divya, Monk, Bradley J.

Volltext

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer von Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R., Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp‐Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean‐Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Andreas

Volltext

Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study von Oza, Amit M, Selle, Frédéric, Davidenko, Irina, Korach, Jacob, Mendiola, Cesar, Pautier, Patricia, Chmielowska, Ewa, Bamias, Aristotelis, DeCensi, Andrea, Zvirbule, Zanete, González-Martín, Antonio, Hegg, Roberto, Joly, Florence, Zamagni, Claudio, Gadducci, Angiolo, Martin, Nicolas, Robb, Stephen, Colombo, Nicoletta

Volltext

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-wor... von Rubio, María Jesús, Manzano, Aránzazu, de Sande, Luis Miguel, Estévez-García, Purificación, Gordon, María Del Mar, de Prado, Diego Soto, de Aranguiz, Blanca Hernando Fernández, Guerra-Alia, Eva M, Carbó-Bagué, Anna, Romero, Ignacio, Corbellas, Miguel, González-Haba, Alba, Robles-Barraza, Carlos E, Martínez-García, Jerónimo, González-Martín, Antonio

Volltext

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer von Hergueta-Redondo, Marta, Sarrio, David, Molina-Crespo, Ángela, Vicario, Rocío, Bernadó-Morales, Cristina, Martínez, Lidia, Rojo-Sebastián, Alejandro, Serra-Musach, Jordi, Mota, Alba, Martínez-Ramírez, Ángel, Castilla, Mª Ángeles, González-Martin, Antonio, Pernas, Sonia, Cano, Amparo, Cortes, Javier, Nuciforo, Paolo G, Peg, Vicente, Palacios, José, Pujana, Miguel Ángel, Arribas, Joaquín, Moreno-Bueno, Gema

Volltext

Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico von Rubi-Castellanos, Rodrigo, Martínez-Cortés, Gabriela, Francisco Muñoz-Valle, José, González-Martín, Antonio, Cerda-Flores, Ricardo M., Anaya-Palafox, Manuel, Rangel-Villalobos, Héctor

Volltext

Importance of the geographic barriers to promote gene drift and avoid pre- and post-Columbian gene flow in Mexican native groups: Evidence from forensic STR Loci von Rangel-Villalobos, Héctor, Martínez-Sevilla, Víctor Manuel, Martínez-Cortés, Gabriela, Aguilar-Velázquez, José Alonso, Sosa-Macías, Martha, Rubi-Castellanos, Rodrigo, González-Martín, Antonio

Volltext

Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study von Yubero, Alfonso, Barquín, Aranzazu, Estévez, Purificación, Pajares, Bella, Sánchez, Luisa, Reche, Piedad, Alarcón, Jesús, Calzas, Julia, Gaba, Lydia, Fuentes, José, Santaballa, Ana, Salvador, Carmen, Manso, Luis, Herrero, Ana, Taus, Ãlvaro, Márquez, Raúl, Madani, Julia, Merino, María, Marquina, Gloria, Casado, Victoria, Constenla, Manuel, Gutiérrez, María, Dosil, Alba, González-Martín, Antonio

Volltext

Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge von Senent, Yaiza, Inoges, Susana, Lopez-Diaz de Cerio, Ascension, Blanco, Andres, Campo, Arantxa, Carmona-Torre, Francisco, Sunsundegui, Patricia, Gonzalez-Martin, Antonio, Ajona, Daniel, Okroj, Marcin, Prosper, Felipe, Pio, Ruben, Yuste, Jose Ramon, Tavira, Beatriz

Volltext

Demographic History of Indigenous Populations in Mesoamerica Based on mtDNA Sequence Data von González-Martín, Antonio, Gorostiza, Amaya, Regalado-Liu, Lucía, Arroyo-Peña, Sergio, Tirado, Sergio, Nuño-Arana, Ismael, Rubi-Castellanos, Rodrigo, Sandoval, Karla, Coble, Michael D, Rangel-Villalobos, Héctor

Volltext

Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-control... von Banerjee, Susana, Moore, Kathleen N, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H, Holmes, Eileen, Lowe, Elizabeth S, DiSilvestro, Paul

Volltext

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial von DiSilvestro, Paul, Banerjee, Susana, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William, Mathews, Cara, Liu, Joyce, McNamara, John, Lowe, Elizabeth S, Ah-See, Mei-Lin, Moore, Kathleen N

Volltext

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, pha... von Coleman, Robert L, Lorusso, Domenica, Gennigens, Christine, González-Martín, Antonio, Randall, Leslie, Cibula, David, Lund, Bente, Woelber, Linn, Pignata, Sandro, Forget, Frederic, Redondo, Andrés, Vindeløv, Signe Diness, Chen, Menghui, Harris, Jeffrey R, Smith, Margaret, Nicacio, Leonardo Viana, Teng, Melinda S L, Laenen, Annouschka, Rangwala, Reshma, Manso, Luis, Mirza, Mansoor, Monk, Bradley J, Vergote, Ignace, Raspagliesi, Francesco, Melichar, Bohuslav, Gaba Garcia, Lydia, Jackson, Amanda, Henry, Stephanie, Kral, Zdenek, Harter, Philipp, De Giorgi, Ugo, Bjurberg, Maria, Gold, Michael, O'Malley, David, Honhon, Brigitte, Vulsteke, Christof, De Cuypere, Eveline, Denys, Hannelore, Baurain, Jean-Francois, Zamagni, Claudio, Tenney, Meaghan, Gordinier, Mary, Bradley, William, Schlumbrecht, Matthew, Spirtos, Nicola, Concin, Nicole, Mahner, Sven, Scambia, Giovanni, Leath, Charles, Farias-Eisner, Robin, Cohen, Joshua, Muller, Carolyn, Bhatia, Sumeet

Volltext

Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program von Yubero, Alfonso, Estévez, Purificación, Barquín, Aránzazu, Sánchez, Luisa, Santaballa, Ana, Pajares, Bella, Reche, Piedad, Salvador, Carmen, Manso, Luis, Márquez, Raúl, González-Martín, Antonio

Volltext

Progress in PARP inhibitors beyond BRCA mutant recurrent ovarian cancer? von Gonzalez Martin, Antonio

Volltext